Works matching DE "PANITUMUMAB"

Results: 93
    1

    Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
    By:
    • Ciardiello, Davide;
    • Martinelli, Erika;
    • Troiani, Teresa;
    • Mauri, Gianluca;
    • Rossini, Daniele;
    • Martini, Giulia;
    • Napolitano, Stefania;
    • Famiglietti, Vincenzo;
    • Del Tufo, Sara;
    • Masi, Gianluca;
    • Santini, Daniele;
    • Avallone, Antonio;
    • Pietrantonio, Filippo;
    • Lonardi, Sara;
    • Di Maio, Massimo;
    • Zampino, Maria Giulia;
    • Fazio, Nicola;
    • Bardelli, Alberto;
    • Siena, Salvatore;
    • Cremolini, Chiara
    Publication type:
    Article
    2
    3
    4
    5
    6

    Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2681, doi. 10.1007/s00432-020-03257-z
    By:
    • Kurreck, A.;
    • Geissler, M.;
    • Martens, U. M.;
    • Riera-Knorrenschild, J.;
    • Greeve, J.;
    • Florschütz, A.;
    • Wessendorf, S.;
    • Ettrich, T.;
    • Kanzler, S.;
    • Nörenberg, D.;
    • Seidensticker, M.;
    • Held, S.;
    • Buechner-Steudel, P.;
    • Atzpodien, J.;
    • Heinemann, V.;
    • Stintzing, S.;
    • Seufferlein, T.;
    • Tannapfel, A.;
    • Reinacher-Schick, A. C.;
    • Modest, D. P.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

    Published in:
    Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 3, p. 404, doi. 10.1177/10781552241241004
    By:
    • Yildirim, Mahmut Emre;
    • Karadurmuş, Nuri;
    • Ökten, İlker Nihat;
    • Türk, Hacı Mehmet;
    • Urakçı, Zuhat;
    • Arslan, Çağatay;
    • Çelik, Sinemis;
    • Dane, Faysal;
    • Şendur, Mehmet Ali Nahit;
    • Bilir, Cemil;
    • Karabulut, Bülent;
    • Cicin, İrfan;
    • Çubukçu, Erdem;
    • Karaca, Mustafa;
    • Ozcelik, Melike;
    • Artaç, Mehmet;
    • Tanrikulu, Eda;
    • Alacacioglu, Ahmet;
    • Açıkgöz, Özgür;
    • Öven, Başak
    Publication type:
    Article
    15
    16

    Panitumumab Associated Acute Pancreatitis.

    Published in:
    Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1207, doi. 10.1177/10781552221073997
    By:
    • Arbag, Huseyin Can;
    • Sumbul, Hilmi Erdem;
    • Buyuksimsek, Mahmut;
    • Ogul, Ali;
    • Yetisir, Abdullah Evren;
    • Koseci, Tolga;
    • Bozkurt Duman, Berna;
    • Tohumcuoglu, Mert;
    • Kesen, Oguzhan;
    • Cil, Timucin
    Publication type:
    Article
    17

    Erratum.

    Published in:
    2024
    Publication type:
    Correction Notice
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases--a phase II study.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231600
    By:
    • Piringer, Gudrun;
    • Gruenberger, Thomas;
    • Thaler, Josef;
    • Kührer, Irene;
    • Kaczirek, Klaus;
    • Längle, Friedrich;
    • Viragos-Toth, Istvan;
    • Amann, Arno;
    • Eisterer, Wolfgang;
    • Függer, Reinhold;
    • Andel, Johannes;
    • Pichler, Angelika;
    • Stift, Judith;
    • Sölkner, Lidija;
    • Gnant, Michael;
    • Öfner, Dietmar
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36

    Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86966-w
    By:
    • Trilla-Fuertes, Lucía;
    • Gámez-Pozo, Angelo;
    • Maurel, Joan;
    • Garcia-Carbonero, Rocio;
    • Capdevila, Jaume;
    • G-Pastrián, Laura;
    • Mendiola, Marta;
    • Peña, Cristina;
    • López-Vacas, Rocío;
    • Cuatrecasas, Miriam;
    • García-Alfonso, Pilar;
    • Ramos-Ruiz, Ricardo;
    • Llorens, Carlos;
    • Ghanem, Ismael;
    • Conill, Carles;
    • Heredia-Soto, Victoria;
    • Campos-Barros, Ángel;
    • Fresno Vara, Juan Ángel;
    • Feliu, Jaime
    Publication type:
    Article
    37

    Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies.

    Published in:
    Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1027890
    By:
    • Opo, F. A. Dain Md;
    • Moulay, Mohammed;
    • Zari, Ali;
    • Alqaderi, Afnan;
    • Alkarim, Saleh;
    • Zari, Talal;
    • Bhuiyan, Mohiuddin Ahmed;
    • Mahmoud, Maged Mostafa;
    • Aljoud, Fadwa;
    • Suhail, Mohd;
    • Edris, Sherif;
    • Ramadan, Wafaa S.;
    • Kamal, Mohammad Amjad;
    • Nemmiche, Saïd;
    • Ahammad, Foysal
    Publication type:
    Article
    38
    39
    40

    The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity.

    Published in:
    Cancers, 2024, v. 16, n. 22, p. 3847, doi. 10.3390/cancers16223847
    By:
    • Vonica, Razvan Constantin;
    • Butuca, Anca;
    • Vonica-Tincu, Andreea Loredana;
    • Morgovan, Claudiu;
    • Pumnea, Manuela;
    • Cipaian, Remus Calin;
    • Curca, Razvan Ovidiu;
    • Batar, Florina;
    • Vornicu, Vlad;
    • Solomon, Adelaida;
    • Frum, Adina;
    • Dobrea, Carmen Maximiliana;
    • Axente, Dan Damian;
    • Gligor, Felicia Gabriela
    Publication type:
    Article
    41

    The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting—A Nation-Wide Retrospective Analysis (RACER).

    Published in:
    Cancers, 2023, v. 15, n. 17, p. 4361, doi. 10.3390/cancers15174361
    By:
    • Potocki, Paweł Michał;
    • Wiśniowski, Rafał;
    • Haus, Dominik;
    • Chowaniec, Zbyszko;
    • Kozaczka, Maciej;
    • Kustra, Magdalena;
    • Samborska-Plewicka, Marzenna;
    • Szweda, Marcin;
    • Starzyczny-Słota, Danuta;
    • Michalik, Magdalena;
    • Słomian, Grzegorz;
    • Lebiedzińska, Aneta;
    • Jonak-Olczyk, Natalia;
    • Łaszewska-Kraińska, Natalia;
    • Adamowicz, Krzysztof;
    • Kolenda, Piotr;
    • Drosik-Kwaśniewska, Anna;
    • Szwiec, Marek;
    • Dziura, Robert;
    • Czech, Justyna
    Publication type:
    Article
    42
    43
    44
    45
    46

    Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1450, doi. 10.1007/s10147-022-02208-7
    By:
    • Ito, Takahiko;
    • Takashima, Atsuo;
    • Yamazaki, Kentaro;
    • Yukami, Hiroki;
    • Uetake, Hiroyuki;
    • Tsuda, Masahiro;
    • Suto, Takeshi;
    • Moriwaki, Toshikazu;
    • Sugimoto, Naotoshi;
    • Ojima, Hitoshi;
    • Takii, Yasumasa;
    • Yasui, Hisateru;
    • Esaki, Taito;
    • Tsuji, Akihito;
    • Goto, Masahiro;
    • Saruta, Masayuki;
    • Otsu, Satoshi;
    • Shinozaki, Katsunori;
    • Fujiwara, Toshiyoshi;
    • Tamura, Takao
    Publication type:
    Article
    47

    Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
    By:
    • Kato, Takeshi;
    • Kagawa, Yoshinori;
    • Kuboki, Yasutoshi;
    • Gamoh, Makio;
    • Komatsu, Yoshito;
    • Yasui, Hirofumi;
    • Satake, Hironaga;
    • Oki, Eiji;
    • Tanioka, Hiroaki;
    • Kotaka, Masahito;
    • Makiyama, Akitaka;
    • Denda, Tadamichi;
    • Goto, Masahiro;
    • Yoshino, Takayuki;
    • Yamazaki, Kentaro;
    • Soeda, Junpei;
    • Shibuya, Kazunori;
    • Iwata, Masaru;
    • Oba, Koji;
    • Yamaguchi, Kensei
    Publication type:
    Article
    48
    49

    Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.

    Published in:
    Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
    By:
    • Spiekman, Ilse A C;
    • Geurts, Birgit S;
    • Zeverijn, Laurien J;
    • Wit, Gijs F de;
    • van der Noort, Vincent;
    • Roepman, Paul;
    • Leng, Wendy W J de;
    • Jansen, Anne M L;
    • Kusters, Benno;
    • Beerepoot, Laurens V;
    • Vos, Filip Y F L de;
    • Groot, Derk-Jan A de;
    • Groot, Jan Willem B de;
    • Hoeben, Ann;
    • Buter, Jan;
    • Gelderblom, Hans A J;
    • Voest, Emile E;
    • Verheul, Henk M W
    Publication type:
    Article
    50